Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETs

Clinical trial NCT04852679 · COMPLETED

Trial details

NCT number: NCT04852679
Sponsor: Ipsen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gastroenteropancreatic Neuroendocrine Tumor

Start date: 2021-05-24
Primary completion: 2022-06-10
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.